Accelero Bioanalytics provides a comprehensive test method portfolio. From early-stage project setup (target identification, cloning, cell culture ... etc. ) up to in vivo drug product characterization (toxicokinetic profiling, pharmacodynamics, blood cell characterization ... etc. ) - Accelero covers nearly all stages of the typical drug substance / drug product development.
ELISA & Hybridization
Assay setup and validation, PK/PD bioanalysis for GLP and GCP (GCLP) studies.
Real Time qPCR & RTqPCR
Assay development and validation for GLP and GCP (GCLP) studies.
Flow Cytometry (FACS)
Bacterial or mammalian cell isolation, culture, characterization - multiplex assay setup and validation for GLP and GCP (GCLP) studies.
New: Particle-based multiplex FirePlex® immunoassays.
New: Particle-based multiplex FirePlex® miRNA profiling assays, directly from biofluids, no extraction required.
FirePlex® is the new name for Abcam´s Firefly assays. FIREPLEX is a trademark registered by Abcam plc in the United States, and is an unregistered trademark elsewhere.
NEW: EliSpot & Triple FluoroSpot
Most sensitive immunoassays, 3-channel detection - setup and validation for GLP and GCP (GCLP) studies.
RNA and Protein biomarker identification utilizing microarray glass slide technology - binding partner identfication.
Pharmacokinetic / Toxicokinetic / Statistical Analysis
Data analysis for PK profiling e.g. for different routes of administration, GCP Phase 1 dose escalation studies.
Supply Chain: Sample Collection / Clinical Kits and GxP Shipment Organisation
We provide clinical kits and organize the complete sample collection and shipment for your GxP studies.
Last update of this site: 05-FEB-2018 by Christian Lange